BioMerieux SA BIM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €101.50
- Day Range
- €101.20–102.30
- 52-Week Range
- €84.54–108.90
- Bid/Ask
- €0.00 / €102.50
- Market Cap
- €12.09 Bil
- Volume/Avg
- 86,178 / 99,808
Key Statistics
- Price/Earnings (Normalized)
- 20.52
- Price/Sales
- 3.31
- Dividend Yield (Trailing)
- 0.83%
- Dividend Yield (Forward)
- 0.83%
- Total Yield
- 0.83%
Company Profile
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 13,982
- Website
- http://www.biomerieux.com
Comparables
Valuation
|
Metric
|
BIM
|
TIHE
|
HLS
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.52 | — | 2.40 |
Price/Book Value | 3.24 | — | 0.84 |
Price/Sales | 3.31 | — | 0.44 |
Price/Cash Flow | 18.74 | — | 2.60 |
Price/Earnings
BIM
TIHE
HLS
Financial Strength
|
Metric
|
BIM
|
TIHE
|
HLS
|
|---|---|---|---|
Quick Ratio | 1.19 | — | 0.44 |
Current Ratio | 2.03 | — | 0.53 |
Interest Coverage | 100.18 | — | −13.26 |
Quick Ratio
BIM
TIHE
HLS
Profitability
|
Metric
|
BIM
|
TIHE
|
HLS
|
|---|---|---|---|
Return on Assets (Normalized) | 8.46% | — | 0.10% |
Return on Equity (Normalized) | 12.00% | — | 0.23% |
Return on Invested Capital (Normalized) | 10.49% | — | 2.27% |
Return on Assets
BIM
TIHE
HLS
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Gscpxwdv | Xsknj | $220.2 Bil | |
DHR
| Danaher Corp | Lxbypjtt | Ptvxlk | $182.8 Bil | |
IQV
| IQVIA Holdings Inc | Jbgkjrd | Dmlqdj | $42.9 Bil | |
IDXX
| IDEXX Laboratories Inc | Xcnbvpvhz | Gxrls | $42.0 Bil | |
A
| Agilent Technologies Inc | Cvcdzwqtwj | Fqw | $40.9 Bil | |
MTD
| Mettler-Toledo International Inc | Qwrdxxrl | Dgwhss | $26.8 Bil | |
ICLR
| Icon PLC | Pnflhxzwg | Ryxssqq | $25.1 Bil | |
ILMN
| Illumina Inc | Fqqzwbr | Spfbbb | $19.9 Bil | |
WAT
| Waters Corp | Cpsjmgjl | Zzw | $18.7 Bil | |
LH
| Laboratory Corp of America Holdings | Tlnvbcxf | Qsllsn | $17.2 Bil |